|
|
| LT012: |
β-N-Oxalyl-L-α ,β -Diaminopropionic acid (L-ODAP)
|
| |
HOOC.CO.NH.CH2.CH.(NH2).COOH
|
|
Unusual amino
acid from Lathryus sativus seeds with demonstrable
neurotoxicity in experimental animals(1-4) an Inhibitor of Tryosine
amino transaminase(5) and is the only known naturally occuring
compound to inhibit this enzyme and a putative non NMDA receptor
agonist (6-8) and inhibits mitochondrial complex I in the CNS(9).
|
|
LT013:
|
β-N-Oxalyl-D-α ,β -Diaminopropionic acid (D-ODAP)
|
|
HOOC.CO.NH.CH2.CH.(NH2).COOH
|
|
|
A non neurotoxic isomer of L-ODAP(10).
|
|
LT014:
|
L- α, β-Diaminopropionic acid
HCl (L-DAP)
|
|
NH2.CH2CH.(NH2).COOH
|
|
A nontoxic amino acid but can
inhibit glutamate binding to synpatic membranes(8).
|
|
LT015:
|
D- α,β -Diaminopropionic acid
HCl (D-DAP)
|
|
NH2.CH2CH.(NH2).COOH
|
|
|
A constituent of some antibiotics
and inhibitor of microbial growth.
|
|
LT016:
|
β-N-Acetyl-L-α,β -Diaminopropionic acid
(ADAP)
|
|
|
CH3.CO.NH.CH2.CH.(NH2).COOH
|
|
A nonneurotoxic analogue of ODAP but
can pontentiate NMDA evoked currents(11).
|
|
LT017:
|
β-N-Carboxymethyl L-α,β -Diaminopropionic acid(CMDAP)
|
|
HOOC.CH2.NH.CH2.CH.(NH2).COOH
|
|
A nonneurotoxic analogue of ODAP but
can activate sensitive NMDA Receptors(11).
|
|
LT018: |
γ-N-Oxalyl-L-α, γ-Diaminobutyric acid (L-ODAB)
|
|
HOOC.CO.NH.CH2.CH2.CH.(NH2).COOH
|
|
A neuroactive principle found in some
lathryus species and presumably acts at certain receptor in the CNS. |
|
|
|